Larkai Healthcare, a global medtech startup, has raised $500,000 in a seed funding round co-led by FAAD Network, QI Ventures, and RTAF, and included additional government grants. The startup specializes in creating advanced, affordable, and accessible healthcare solutions.
Abhilash Chakraverty, Co-Founder and Director of Larkai Healthcare said, "Seizing this opportunity, we are poised to bridge the gap between diagnosis and treatment, leveraging our global footprint and robust intellectual assets. This fuels our vision for healthcare—transcending borders, transforming lives, and setting new benchmarks in accessibility and innovation."
What does Larkai Healthcare do?
Founded in 2020 by Pritam Dhalla and Abhilash Chakraverty, Larkai Healthcare offers a device for early-stage heart impulse and valvular disease diagnosis, a smart inhaler cap to reduce drug wastage and a cost-effective disinfection tunnel.
The startup is aimed at bridging the gap between diagnosis and treatment with its advanced AI technology.
Amplifying sales verticals
With the new funding, Larkai Healthcare plans will focus on technological advancements and amplify its sales verticals through strategic investment.
Dr Dinesh Singh, Co-Founder and Director of FAAD Network, stated, "Investing in Larkai stands as a testament to our unwavering dedication to spearheading impactful change in the realm of technology ventures. Their groundbreaking AI-infused approach resonates deeply with our mission."
What is FAAD Network?
FAAD Network, which recently received approval from the Securities and Exchange Board of India (SEBI) for a Rs 300 crore Alternative Investment Fund (AIF), focuses on supporting early-stage technology startups in India.
So far, It has invested in over 75 startups and a network of 2000+ Angels, HNIs, and VCs.
Join our new WhatsApp Channel for the latest startup news updates